Log In
Print this Print this

HVTN 100

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionCombination of Alvac-HIV (vCP205), a live recombinant canarypox vector vaccine expressing HIV gp120, HIV gag and HIV protease from Sanofi, and an HIV gp120 protein vaccine and MF59 adjuvant from Novartis AG
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationHIV / AIDS
Indication DetailsPrevent HIV subtype C infection
Regulatory Designation
PartnerNovartis AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today